Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta-analysis

BACKGROUND: Antibody-drug conjugates are attractive targeted agents in anticancer treatment because of their unique mechanism of action and reduced toxicity. Little is known about the spectrum of adverse events associated with antibody-drug conjugates, despite tens of clinical trials. METHODS: A sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yukio, Zhou, Susu, Ota, Yukihide, Harrington, Matthew, Miyagi, Etsuko, Takagi, Hisato, Kuno, Toshiki, Wright, Jason D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579782/
https://www.ncbi.nlm.nih.gov/pubmed/37756687
http://dx.doi.org/10.1093/jncics/pkad069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579782/
https://www.ncbi.nlm.nih.gov/pubmed/37756687
http://dx.doi.org/10.1093/jncics/pkad069

Ejemplares similares